Chronic Disease

Reports of high-impact chronic disease studies by medical professionals

No benefit with hydroxychloroquine (Plaquenil) over placebo in Sjogren’s Syndrome [JOQUER Trial]

1. Isaclimab significantly improved disease activity at 150 mg and 600 mg doses. 2. Adverse events were comparable between cohorts...

Page 2 of 453 1 2 3 453